| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,295,109 | 1,303,640 | 1,312,419 | 1,237,402 | | Cost of Revenue | (1,117,906) | 576,609 | 541,297 | (174,708) | | | Gross Profit | 2,413,015 | 727,031 | 771,122 | 1,412,110 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,118,847 | 392,233 | 464,260 | 1,161,488 | | Non Recurring | 380,734 |
-
|
-
|
-
| | Others | (188,443) | 171,755 | 170,112 | 162,390 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 101,877 | 163,043 | 136,750 | 88,232 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (10,987) | | Earnings Before Interest And Taxes | 66,580 | 163,043 | 136,750 | 70,574 | | Interest Expense | (24,517) | 11,879 | 12,638 | 2,073 | | Income Before Tax | 91,097 | 151,164 | 124,112 | 68,501 | | Income Tax Expense | 32,043 | 57,187 | 42,078 | 28,026 | | Minority Interest | (7,980) | (13,084) | (14,493) | (6,671) | | | | Net Income From Continuing Ops | 86,631 | 80,893 | 67,541 | 40,475 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 6,002 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 51,074 | 80,893 | 67,541 | 46,477 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $51,074 | $80,893 | $67,541 | $46,477 |
|
0.06% Nasdaq 
Income Statement
